139 related articles for article (PubMed ID: 9890384)
1. Inhibition of nitric oxide metabolism enhances the hypnotic-anesthetic action of the alpha2-adrenoceptor agonist dexmedetomidine in vivo.
Tonner PH; Scholz J; Schlamp N; Schulte am Esch J
J Neurosurg Anesthesiol; 1999 Jan; 11(1):37-41. PubMed ID: 9890384
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in Xenopus laevis.
Tonner PH; Scholz J; Lamberz L; Schlamp N; Schulte am Esch J
Anesthesiology; 1997 Dec; 87(6):1479-85. PubMed ID: 9416733
[TBL] [Abstract][Full Text] [Related]
3. [L-nitroargininemethylester (L-NAME), a nitric oxide synthase inhibitor, increases the anesthetic potency of etomidate].
Tonner PH; Scholz J; Suppé E; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Mar; 34(3):136-9. PubMed ID: 10234408
[TBL] [Abstract][Full Text] [Related]
4. Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain.
Vulliemoz Y; Shen H; Virag L
Anesthesiology; 1996 Sep; 85(3):544-50. PubMed ID: 8853084
[TBL] [Abstract][Full Text] [Related]
5. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
[TBL] [Abstract][Full Text] [Related]
6. The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.
Vulliemoz Y; Whittington RA; Virag L
Brain Res; 1999 Dec; 849(1-2):169-74. PubMed ID: 10592299
[TBL] [Abstract][Full Text] [Related]
7. The effects of nitric oxide synthase inhibitors on the sedative effect of clonidine.
Soares de Moura R; Rios AA; de Oliveira LF; Resende AC; de Lemos Neto M; Santos EJ; Correia ML; Tano T
Anesth Analg; 2001 Nov; 93(5):1217-21. PubMed ID: 11682401
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments.
Ishiyama T; Dohi S; Iida H; Watanabe Y; Shimonaka H
Anesth Analg; 1995 Dec; 81(6):1208-15. PubMed ID: 7486106
[TBL] [Abstract][Full Text] [Related]
9. Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats.
Horvàth G; Szikszay M; Benedek G
Anesth Analg; 1992 Jun; 74(6):884-8. PubMed ID: 1375817
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors.
Doze VA; Chen BX; Maze M
Anesthesiology; 1989 Jul; 71(1):75-9. PubMed ID: 2568769
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
[TBL] [Abstract][Full Text] [Related]
12. The anesthetic effect of dexmedetomidine does not adhere to the Meyer-Overton rule but is reversed by hydrostatic pressure.
Tonner PH; Scholz J; Koch C; Schulte am Esch J
Anesth Analg; 1997 Mar; 84(3):618-22. PubMed ID: 9052313
[TBL] [Abstract][Full Text] [Related]
13. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine.
Horváth G; Kovács M; Szikszay M; Benedek G
Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240
[TBL] [Abstract][Full Text] [Related]
14. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
[TBL] [Abstract][Full Text] [Related]
15. Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis.
Aleixandre A; López-Miranda V; Ortega A
J Cardiovasc Pharmacol; 2001 Feb; 37(2):133-42. PubMed ID: 11209996
[TBL] [Abstract][Full Text] [Related]
16. Chronic desipramine treatment desensitizes the rat to anesthetic and antinociceptive effects of the alpha2-adrenergic agonist dexmedetomidine.
Guo TZ; Reid K; Davies MF; Nacif-Coelho C; Rabin BC; Gonzalez F; Maze M
Anesthesiology; 1998 Jun; 88(6):1634-42. PubMed ID: 9637658
[TBL] [Abstract][Full Text] [Related]
17. Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.
Snapir A; Talke P; Posti J; Huiku M; Kentala E; Scheinin M
Br J Anaesth; 2009 Jan; 102(1):38-46. PubMed ID: 18987056
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of hypnotic-anesthetic actions of alpha 2 agonists from cyclic AMP in the rat.
Rabin BC; Guo TZ; Maze M
Pharmacol Biochem Behav; 1997; 57(1-2):23-9. PubMed ID: 9164550
[TBL] [Abstract][Full Text] [Related]
20. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
